Premedication with reformulated simethicone and sodium bicarbonate improves mucosal visibility during upper gastrointestinal endoscopy: a double-blind, multicenter, randomized controlled trial

4Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The reformulated simethicone emulsion from Berlin Chemical AG might develop white flocculate precipitate covering the gastric mucosa when used before esophagogastroduodenoscopy (EGD). We aim to investigate whether combining the reformulated simethicone emulsion with 5% sodium bicarbonate solution could prevent the development of white precipitate and improve visibility during EGD. Methods: Our clinical study involved 523 patients. They were randomly assigned to two groups. In Group A, patients received a warm solution containing 30 ml 5% sodium bicarbonate solution and 15 ml reformulated simethicone emulsion. In Group B, patients received 45 ml 40 °C lukewarm water. Visibility scores were recorded and analyzed. Flushes, volume of flush water, overall time taken for EGD and complications during or after the procedure were also recorded. Results: We found that no white precipitate was observed during EGD in Group A. Moreover, visibility scores in Group A were significantly lower (P < 0.01). Patients in Group A had fewer flushes (P < 0.01) and smaller volume of flush water (P < 0.01). In addition, the overall time taken for the EGD procedure was significantly shorter in Group A (P < 0.01). The percentage of patients who had no adverse response was significantly higher in Group A than in Group B (P < 0.01). Conclusions: Premedication with a mixed solution of 15 ml reformulated simethicone emulsion and 30 ml 5% sodium bicarbonate solution can prevent the development of white precipitate, substantially enhancing mucosal visibility safely. Trial registration: The registered name of the trial is “Efficacy of using premedication with reformulated simethicone emulsion during upper gastrointestinal endoscopy examination”. Its Current Controlled Trials number is ChiCTR1900021689. Its date of registration is 11 September 2019. Retrospectively registered, http://www.medresman.org.cn/uc/sindex.aspx.

References Powered by Scopus

Endoscopic mucosal resection

233Citations
N/AReaders
Get full text

Use of Residual Volume as a Marker for Enteral Feeding Intolerance: Prospective Blinded Comparison With Physical Examination and Radiographic Findings

179Citations
N/AReaders
Get full text

Missed diagnoses in patients with upper gastrointestinal cancers

168Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Minimizing the Risks of Simethicone in Endoscope Reprocessing

3Citations
N/AReaders
Get full text

Clinical features of magnetically controlled capsule endoscopy in children: A large, retrospective cohort study

0Citations
N/AReaders
Get full text

Use of N-acetylcysteine plus simethicone to improve mucosal visibility in upper digestive endoscopy via systematic alphanumeric-coded endoscopy: a randomized, double-blind controlled trial

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chen, X., Dai, N., Deng, Y., Sun, X., Zhang, M., Pan, J., … Chen, S. (2021). Premedication with reformulated simethicone and sodium bicarbonate improves mucosal visibility during upper gastrointestinal endoscopy: a double-blind, multicenter, randomized controlled trial. BMC Gastroenterology, 21(1). https://doi.org/10.1186/s12876-021-01623-w

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

75%

Professor / Associate Prof. 1

13%

Researcher 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

50%

Pharmacology, Toxicology and Pharmaceut... 2

20%

Sports and Recreations 2

20%

Biochemistry, Genetics and Molecular Bi... 1

10%

Save time finding and organizing research with Mendeley

Sign up for free